form8_k.htm  


SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported):  September 22, 2011 (September 22, 2011)


CHEMBIO DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
 
Nevada
 
0-30379
 
88-0425691
(State or other jurisdiction
 
(Commission File Number)
 
(IRS Employer
of Incorporation)
     
Identification Number)
   
3661 Horseblock Road
   
   
Medford, NY 11763
   
   
(Address of principal executive offices)
   
   
631-924-1135
   
   
(Registrant’s Telephone Number)
   
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 


 
 
 
 

 
 
 
 


Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

At the Company’s annual stockholder meeting on September 22, 2011, stockholders elected directors of the Company to serve until the next annual meeting of stockholders or until their respective successors are elected and qualified.  Stockholders also ratified the selection of BDO USA LLP as the Company’s independent registered certified accountants to audit the Company’s financial statements as of and for the year ending December 31, 2011, authorized the Board of Directors to determine whether to effect a reverse stock split, in a range from 5 for 1 to 15 for 1, and approved amending the Company’s 2008 Stock Incentive Plan to increase the number of shares covered by 1,000,000 ..  A tabulation of the matters voted on at this annual stockholder meeting is set forth below.

Proposal #1:– Election of Directors
 
Kathy L. Davis
 
Barbara D. DeBuono
 
Peter Kissinger
 
Dr. Gary Meller
 
  Lawrence A. Siebert
For
 
26,461,602
 
26,601,395
 
26,597,895
 
26,563,295
 
26,563,295
Withheld/Against
 
234,148
 
94,355
 
97,855
 
132,455
 
132,455
Broker non votes
 
36,607,680
 
36,607,680
 
36,607,680
 
36,607,680
 
36,607,680

 
Proposal
 
Ratifying BDO USA LLP as the Company’s Independent Auditors for the year ending December 31, 2011
 
Authorize BOD  to determine whether to effect a reverse split
 
Approve amendment to the 2008 Stock Incentive Plan
 
 Vote to Adjourn Or Postpone the meeting
 
Vote on Other Business
For
 
55,362,267
 
50,285,361 
 
26,514,547
 
51,821,338
 
53,025,978
Withheld/Against
 
500
 
4,799,364
 
647,415
 
2,716,117
 
942,317
Abstain
 
144,229
 
422,271 
 
194,051
 
969,541
 
1,538,701
Broker non votes
 
7,796,434
 
7,796,434
 
35,947,417
 
7,796,434
 
7,796,434

 

 


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date:  September 22, 2011                                                                  Chembio Diagnostics, Inc.



By:    /s/ Lawrence A. Siebert                                      
Lawrence A. Siebert
Chief Executive Officer